[go: up one dir, main page]

BRPI0507349A - genes associados á osteoartrite canina e processos e composições relacionados - Google Patents

genes associados á osteoartrite canina e processos e composições relacionados

Info

Publication number
BRPI0507349A
BRPI0507349A BRPI0507349-9A BRPI0507349A BRPI0507349A BR PI0507349 A BRPI0507349 A BR PI0507349A BR PI0507349 A BRPI0507349 A BR PI0507349A BR PI0507349 A BRPI0507349 A BR PI0507349A
Authority
BR
Brazil
Prior art keywords
osteoarthritis
compositions
genes associated
related processes
canine
Prior art date
Application number
BRPI0507349-9A
Other languages
English (en)
Inventor
Rondo P Middleton
Steven S Hannah
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0507349A publication Critical patent/BRPI0507349A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

"GENES ASSOCIADOS à OSTEOARTRITE CANINA E PROCESSOS E COMPOSIçõES RELACIONADOS". A presente invenção refere-se a uma combinação contendo moléculas de polinucleotídeos que são expressas diferencialmente na osteoartrite. São descritos ainda os processos que podem ser utilizados para o diagnóstico e para o prognóstico da osteoartrite, assim como os processos que podem ser utilizados para selecionar substâncias de teste em relação à eficiência nas modalidades de tratamento para a osteoartrite. São descritos ainda dispositivos e kits que podem ser utilizados com os processos descritos.
BRPI0507349-9A 2004-02-02 2005-02-02 genes associados á osteoartrite canina e processos e composições relacionados BRPI0507349A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54134604P 2004-02-02 2004-02-02
PCT/US2005/003375 WO2005075685A1 (en) 2004-02-02 2005-02-02 Genes associated with canine osteoarthritis and related methods and compositions

Publications (1)

Publication Number Publication Date
BRPI0507349A true BRPI0507349A (pt) 2007-04-17

Family

ID=34837479

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507349-9A BRPI0507349A (pt) 2004-02-02 2005-02-02 genes associados á osteoartrite canina e processos e composições relacionados

Country Status (9)

Country Link
EP (1) EP1711635A1 (pt)
JP (1) JP4879756B2 (pt)
CN (1) CN1914336B (pt)
AU (1) AU2005210503B2 (pt)
BR (1) BRPI0507349A (pt)
CA (1) CA2555083A1 (pt)
RU (1) RU2341795C2 (pt)
WO (1) WO2005075685A1 (pt)
ZA (1) ZA200607348B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
EP2217721A4 (en) * 2007-10-29 2013-01-09 Univ California OSTEOARTHRITIS-GENE THERAPY
EP2123775A1 (en) * 2008-05-20 2009-11-25 Stiftung Tierärztliche Hochschule Hannover Analysis for the genetic disposition for hip dysplasia in Canidae
US9464330B2 (en) * 2012-12-21 2016-10-11 Pioneer Hi-Bred International, Inc. Genetic loci associated with soybean cyst nematode resistance and methods of use
CN105803085B (zh) * 2016-04-27 2019-07-19 范彧 一种检测骨关节炎的分子标记物及其用途
TWI857807B (zh) * 2020-03-20 2024-10-01 台灣粒線體應用技術股份有限公司 含有粒線體之組合物及其用於作為皮膚纖維母細胞活性促進劑之用途
CN113249464B (zh) * 2021-04-13 2022-09-27 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 环状rna作为骨关节炎标志物的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207657A (pt) * 2001-02-28 2004-10-26 Chondrogene Inc Uma ou mais sequências de polinucleotìdeos isoladas, vetor, célula hospedeira, composição, disposição, métodos para diagnosticar as osteoartrites branda, moderada, acentuada e grave em um paciente, para identificar um agente que aumenta ou diminui a expressão de uma sequência de polinucleotìdeos, para preparar uma coleção de cdna de condrócito, e para fabricar uma disposição, e conjunto

Also Published As

Publication number Publication date
CN1914336A (zh) 2007-02-14
AU2005210503A1 (en) 2005-08-18
WO2005075685A1 (en) 2005-08-18
CA2555083A1 (en) 2005-08-18
JP2007523643A (ja) 2007-08-23
EP1711635A1 (en) 2006-10-18
CN1914336B (zh) 2012-09-19
AU2005210503B2 (en) 2010-02-25
RU2341795C2 (ru) 2008-12-20
ZA200607348B (en) 2008-05-28
RU2006131570A (ru) 2008-03-10
JP4879756B2 (ja) 2012-02-22

Similar Documents

Publication Publication Date Title
BRPI0918670B8 (pt) anticorpo
Li et al. Epigenetic marker (LINE-1 promoter) methylation level was associated with occupational lead exposure
BRPI1013688A8 (pt) Proteínas de ligação de il-17.
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
CL2012003196A1 (es) Anticuerpo aislado o fragmento del mismo que se une específicamente a interleuquina-4 (il-4); molécula de ácido nucleico aislado que lo codifica y vector que la comprende; célula que comprende dicho vector; composición farmacéutica que comprende dicho anticuerpo; y su uso parar tratar una enfermedad alérgica, cáncer y asma.
BR112012001984B8 (pt) anticorpos humanos com alta afinidade para angiopoietina-2 humana, uso dos mesmos e composição farmacêutica
BR112012032537A2 (pt) biomarcadores de câncer de pulmão e suas utilizações
IN2014DN04226A (pt)
EA201301072A1 (ru) Антитела против il-23p19 и их применение
WO2006117596A8 (en) Nucleic acid probes and nucleic acid analog probes
MX2009009200A (es) Tratamiento de enfermedades caracterizadas por la inflamacion.
CL2008002444A1 (es) Anticuerpo o fragmento del mismo que se une a la proteina c-fms humana; molecula de acido nucleico que la codifica; vector y celula huesped; metodo de elaboracion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir una condicion asociada con c-fms en un paciente.
MX2009005781A (es) Moleculas indicadoras resistentes a la oxidacion.
AR063493A1 (es) Nuevos anticuerpos anti notch 3 y su uso para la deteccion y el diagnostico de enfermedades
MX2018004067A (es) Extinguidor que contiene nanomaterial conjugado con polimero soluble en agua y su uso.
CL2009000309A1 (es) Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2.
BR112012029355A2 (pt) sistema à base de ácido nucleico para propagar informações e método para melhorar sistema de computação molecular à base de ácido nucleico
DK1994149T3 (da) Nye fluorescerende proteiner og fremgangsmåder til anvendelse deraf
BR112015029517A2 (pt) método para produzir uma pluralidade de regiões de medida em um chip e chip com regiões de medida
BRPI0507349A (pt) genes associados á osteoartrite canina e processos e composições relacionados
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
BRPI0511292A (pt) kit para fornecer uma refeição para animais de estimação
BRPI0800673A (pt) elementos reguladores de expressão
AR095658A1 (es) Método para la predicción de los síntomas extrapiramidales (sep) inducidos por un tratamiento basado en antipsicóticos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 10A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2291 DE 02/12/2014.